SelectImmune Pharma appoints acting CEO
The company is delighted to announce that Gabriela Godaly will take the role as acting CEO of SelectImmune Pharma until a new permanent CEO has been appointed.Professor Godaly is familiar with all aspects of the company and has been actively involved in its development for several years. She was appointed Chief Medical Officer of SelectImmune Pharma in 2020 and has served on the Board of Directors since 2019. Gabriela Godaly is a clinical trials expert and her contributions are extremely valuable for the rapidly evolving clinical trials program of SelectImmune Pharma. For more